Bayer Secure Raw Materials Supply for Polycarbonate Production

Bayer MaterialScience AG has concluded an agreement for the supply of phenol and acetone in the Europe and Asia regions with the Spanish manufacturer of petrochemical raw materials Ertisa S.A., a subsidiary of the CEPSA Group. Phenol and acetone are used to produce bisphenol A, a base product for the high-tech plastic Makrolon®.

Details of the agreement have not been disclosed.

"We are delighted to enter into this partnership with a renowned supplier.

Security of raw materials supply is a top priority for us," said Patrick Thomas, Chairman of the Board of Management of Bayer MaterialScience, at the signing ceremony with top Spanish managers in Leverkusen.

"The agreement with Ertisa fits in well with our concept, and will help us in future to operate successfully on the market," added Dr. Günter Hilken, head of Bayer MaterialScience’s Polycarbonates Business Unit.

Ertisa S.A., one of the largest phenol and acetone manufacturers in Europe, produces some 600,000 metric tons of phenol a year at its site in Huelva, Spain. From here it is delivered to tanks and plants located on the site of Bayer Antwerpen Comm. V, Belgium for supply to north European customers.

In the future, the raw materials will delivered via a pipeline and by rail from the Antwerp site to Bayer MaterialScience’s bisphenol A processing facilities in Europe. The facilities in Map Ta Phut, Thailand, and Shanghai, China, will be supplied by sea.

"This is an important step for CEPSA in our endeavors to strengthen our partnerships with the most important chemical companies worldwide," said Fernando Iturrieta, Senior Vice President Petrochemicals at CEPSA.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.